Zurcher Kantonalbank (Zurich Cantonalbank) Alpine Immune Sciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $30.1 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
SELL
$17.75 - $41.6 $27,193 - $63,731
-1,532 Reduced 16.06%
8,006 $317,000
Q4 2023

Jan 30, 2024
BUY
$8.54 - $20.22 $81,454 - $192,858
9,538 New
9,538 $181,000
Q4 2022

Feb 01, 2023
SELL
$5.45 - $7.35 $1,803 - $2,432
-331 Reduced 16.19%
1,714 $12,000
Q2 2022

Aug 09, 2022
SELL
$6.71 - $9.52 $1,422 - $2,018
-212 Reduced 9.39%
2,045 $17,000
Q1 2022

Apr 21, 2022
BUY
$6.41 - $13.89 $14,467 - $31,349
2,257 New
2,257 $20,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email